tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

COYA Stock Latest News

Coya Therapeutics: Strong Financial Position and Upcoming Catalysts Support Buy Rating
RatingsCoya Therapeutics: Strong Financial Position and Upcoming Catalysts Support Buy Rating
13d ago
COYA
Coya Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Coya Therapeutics Reports Q3 2025 Financial Results
24d ago
8K
COYA
Coya Therapeutics reports Q3 EPS (13c), consensus (30c)
PremiumThe Fly
Coya Therapeutics reports Q3 EPS (13c), consensus (30c)
24d ago
COYA
Coya Therapeutics price target raised to $17 from $16 at Lake Street
PremiumThe Fly
Coya Therapeutics price target raised to $17 from $16 at Lake Street
1M ago
COYA
Coya Therapeutics announces results from COYA 303 in vivo animal study
PremiumThe Fly
Coya Therapeutics announces results from COYA 303 in vivo animal study
1M ago
COYA
Coya Therapeutics’ Promising ALS Study: A Potential Game-Changer?
PremiumCompany AnnouncementsCoya Therapeutics’ Promising ALS Study: A Potential Game-Changer?
1M ago
COYA
Coya Therapeutics Announces Public Offering of Shares
Premium
Company Announcements
Coya Therapeutics Announces Public Offering of Shares
1M ago
8K
COYA
Coya Therapeutics 3.64M Spot Secondary priced at $5.50
Premium
The Fly
Coya Therapeutics 3.64M Spot Secondary priced at $5.50
1M ago
COYA
Coya Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Coya Therapeutics announces common stock offering, no amount given
1M ago
COYA
Positive Outlook for Coya Therapeutics Driven by Promising COYA-302 Clinical Developments and Regulatory Support
PremiumRatings
Positive Outlook for Coya Therapeutics Driven by Promising COYA-302 Clinical Developments and Regulatory Support
2M ago
COYA
Coya Therapeutics completes enrollment in IL-2 and CTLA4-Ig study
PremiumThe Fly
Coya Therapeutics completes enrollment in IL-2 and CTLA4-Ig study
2M ago
COYA
Promising Outlook for COYA 302 Amidst Phase 2 Trial and Near-Term Catalysts Justifies Buy Rating
PremiumRatings
Promising Outlook for COYA 302 Amidst Phase 2 Trial and Near-Term Catalysts Justifies Buy Rating
2M ago
COYA
Coya Therapeutics launches ALSTARS Trial to study efficacy of COYA 302
PremiumThe FlyCoya Therapeutics launches ALSTARS Trial to study efficacy of COYA 302
3M ago
COYA
Coya Therapeutics’ COYA 303 shows anti-inflammatory effect in animal study
Premium
The Fly
Coya Therapeutics’ COYA 303 shows anti-inflammatory effect in animal study
3M ago
COYA
Coya Therapeutics’ COYA 302 ALS trial accepted by NEALS research consortium
Premium
The Fly
Coya Therapeutics’ COYA 302 ALS trial accepted by NEALS research consortium
3M ago
COYA
Coya Therapeutics Receives $4.2M Milestone Payment
PremiumCompany Announcements
Coya Therapeutics Receives $4.2M Milestone Payment
3M ago
8K
COYA
Coya receives $4.2M milestone payment after FDA approval of IND for Coya 302
PremiumThe Fly
Coya receives $4.2M milestone payment after FDA approval of IND for Coya 302
3M ago
COYA
Positive Outlook for Coya Therapeutics Amid Promising Developments and Financial Stability
PremiumRatings
Positive Outlook for Coya Therapeutics Amid Promising Developments and Financial Stability
3M ago
COYA
Coya Therapeutics Reports Increased Losses Amid Development Focus
PremiumCompany Announcements
Coya Therapeutics Reports Increased Losses Amid Development Focus
4M ago
COYA
Coya Therapeutics files $75M mixed securities shelf
PremiumThe FlyCoya Therapeutics files $75M mixed securities shelf
4M ago
COYA
Coya Therapeutics Highlights Q2 2025 Financial Results
Premium
Company Announcements
Coya Therapeutics Highlights Q2 2025 Financial Results
4M ago
8K
COYA
Coya Therapeutics reports Q2 EPS (36c), consensus (43c)
Premium
The Fly
Coya Therapeutics reports Q2 EPS (36c), consensus (43c)
4M ago
COYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >